Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: J Epidemiol Community Health. 2016 Jun 20;70(11):1114–1121. doi: 10.1136/jech-2015-206302

Table 1.

Characteristics of mothers of twin and singleton infants, National Birth Defects Prevention Study, 1997–2007

Maternal characteristics Controls Cases


Twins (n=218)
n (%)
Singletons (n=7654)
n (%)
p Value* Twins (n=1182)
n (%)
Singletons (n=19 627)
n (%)
p Value*
Any fertility treatment used <0.01 <0.01
 No 147 (67.4) 7408 (96.8) 837 (70.8) 18 798 (95.8)
 Yes 71 (32.6) 246 (3.2) 345 (29.2) 829 (4.2)
  Assisted reproductive technology 39 (17.9) 39 (0.5) <0.01 178 (15.1) 166 (0.9) <0.01
  Clomiphene citrate 19 (8.7) 130 (1.7) <0.01 118 (10.0) 433 (2.2) <0.01
Age at delivery (years) <0.01 <0.01
 <25 38 (17.4) 2554 (33.4) 276 (23.4) 6778 (34.5)
 25–29 49 (22.5) 2105 (27.5) 288 (24.4) 5209 (26.5)
 30–34 77 (35.3) 1922 (25.1) 355 (30.0) 4763 (24.3)
 >34 54 (24.8) 1073 (14.0) 263 (22.3) 2877 (14.7)
Race/ethnicity <0.01 <0.01
 Non-Hispanic white 153 (70.2) 4683 (61.2) 786 (66.5) 11 944 (60.9)
 Non-Hispanic black 31 (14.2) 882 (11.5) 141 (11.9) 2025 (10.3)
 Hispanic 23 (10.6) 1583 (20.7) 168 (14.2) 4320 (22.0)
 Other 11 (5.0) 506 (6.6) 87 (7.3) 1338 (6.8)
Smoking 0.88 <0.01
 Yes 41 (18.8) 1471 (19.2) 194 (16.4) 4300 (21.9)
 No 177 (81.2) 6183 (80.8) 988 (83.6) 15 327 (78.1)
Prepregnancy body mass index (kg/m2) 0.80 0.62
 <30 180 (82.6) 6370 (83.2) 945 (80.0) 15 808 (80.5)
 ≥30 38 (17.4) 1284 (16.8) 237 (20.1) 3819 (19.5)
Parity 0.66 0.17
 No previous live births 91 (41.7) 3082 (40.3) 533 (45.1) 8450 (43.1)
 One or more previous live births 127 (58.3) 4572 (59.7) 649 (54.9) 11 177 (57.0)
Education <0.01 <0.01
 High school graduate or less 57 (26.2) 3047 (39.8) 363 (30.7) 8485 (43.2)
 More than high school graduate 161 (73.9) 4607 (60.2) 819 (69.3) 11 142 (56.8)
Folic acid-containing multivitamin use <0.01 <0.01
 Yes 136 (62.4) 3979 (52.0) 744 (62.9) 9896 (50.4)
 No 82 (37.6) 3675 (48.0) 438 (37.1) 9731 (49.6)
Study site <0.01 <0.01
 Arkansas 19 (8.7) 988 (12.9) 132 (11.2) 2681 (13.7)
 California 6 (2.8) 910 (11.9) 114 (9.6) 2548 (13.0)
 Georgia 23 (10.6) 801 (10.5) 141 (11.9) 2197 (11.2)
 Iowa 35 (16.1) 867 (11.3) 93 (7.9) 1911 (9.7)
 Massachusetts 51 (23.4) 959 (12.5) 240 (20.3) 2581 (13.2)
 New Jersey 26 (11.9) 479 (6.3) 96 (8.1) 1366 (7.0)
 New York 11 (5.1) 682 (5.1) 103 (8.7) 1334 (6.8)
 North Carolina 14 (6.4) 518 (6.8) 58 (4.9) 1057 (5.4)
 Texas 19 (8.7) 868 (11.3) 108 (9.1) 2315 (11.8)
 Utah 14 (6.4) 582 (7.6) 97 (8.2) 1057 (8.3)
*

Mantel-Haenszel χ2 statistics were used to compare group differences for each characteristic of interest.

Any reported use 1 month prior to pregnancy through 3 months after conception.

Any reported use 1 month prior to pregnancy through the first month of pregnancy.